This consensus statement describes the development of multidisciplinary consensus recommendations on the use of staging and surveillance imaging of localized cutaneous squamous cell carcinoma.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Errors in Table 2 | 0 | 10.73 | 01-09-2026 |
| 2 | ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence | 0 | 5.43 | 01-09-2026 |
| 3 | CLIPI and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome | 0 | 8.48 | 07-10-2026 |
| 4 | Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma | 0 | 6.29 | 01-09-2026 |
| 5 | Improved Risk Stratification in Mycosis Fungoides and Sézary Syndrome | 0 | 8.93 | 07-10-2026 |
| 6 | Lumpectomy Margins and Local Recurrence in DCIS | 0 | 8.55 | 01-09-2026 |
| 7 | Melanoma Prevention Among Children of Melanoma Survivors | 0 | 8.06 | 07-10-2026 |
| 8 | High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation | 0 | 8.17 | 01-09-2026 |
| 9 | Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer | 0 | 6.4 | 01-09-2026 |
| 10 | Golimumab in Treatment-Refractory Hidradenitis Suppurativa | 0 | 7.71 | 01-09-2026 |